Abstract 1924: Therapeutic potential of Inhibitor of Apoptosis Protein (IAP) inhibitor APG-1387 combined with DR5 agonist monoclonal antibody (mAb) CTB006 in preclinical models of solid tumors
Home » Abstract 1924: Therapeutic potential of Inhibitor of Apoptosis Protein (IAP) inhibitor APG-1387 combined with DR5 agonist monoclonal antibody (mAb) CTB006 in preclinical models of solid tumors
2021
Li Q, Fang DD, Li Z, Yang D, Cao F, Zhai Y. Abstract 1924: Therapeutic potential of Inhibitor of Apoptosis Protein (IAP) inhibitor APG-1387 combined with DR5 agonist monoclonal antibody (mAb) CTB006 in preclinical models of solid tumors. Cancer Res. vol. 81(suppl 13):, pp. 1924. [2021 AACR poster presentation]-1924. [2021 AACR poster presentation], View